title: Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma.
authors.forename: D H
authors.initials: DH
authors.lastname: Kim
authors.forename: J H
authors.initials: JH
authors.lastname: Baek
authors.forename: Y S
authors.initials: YS
authors.lastname: Chae
authors.forename: Y-K
authors.initials: YK
authors.lastname: Kim
authors.forename: H J
authors.initials: HJ
authors.lastname: Kim
authors.forename: Y H
authors.initials: YH
authors.lastname: Park
authors.forename: H S
authors.initials: HS
authors.lastname: Song
authors.forename: J S
authors.initials: JS
authors.lastname: Chung
authors.forename: M S
authors.initials: MS
authors.lastname: Hyun
authors.forename: S K
authors.initials: SK
authors.lastname: Sohn
mesh_terms: D018951:Antigens, CD20 / Q000096:biosynthesis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D018655:Lymphocyte Count; D008214:Lymphocytes / Q000166:cytology*; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D008495:Medical Oncology / Q000379:methods; D015999:Multivariate Analysis; D016017:Odds Ratio; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D013997:Time Factors; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D018951:Antigens, CD20; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone